Corporate Development

Cubist Pharmaceuticals is a leader in the development and commercialization of acute care drugs for the treatment of unmet medical needs. With a proven track record of success in antibiotics, Cubist has the Clinical, Regulatory and Commercial capacity and expertise to acquire, develop and commercialize pharmaceutical products at any stage of research and development. The Business Development strategy focuses on novel therapeutics (including small molecules, proteins, and antibodies) at any stage of research or development that are consistent with the company's commercial strength in the hospital environment.

To discuss opportunities with Cubist Pharmaceuticals, the Business Development Team recommends that potential collaborators provide a detailed non-confidential package describing the opportunity, including supporting scientific data.